Désolé, cet article est seulement disponible en EN.
Cliquez pour voir la ligne de temps
Ligne de temps
Projets Transversaux
Projets
Publications
Télécharger-
2023Tick-borne flavivirus NS5 antagonizes interferon signaling by inhibiting the catalytic activity of TYK2., EMBO Reports, In press, pp.e57424. ⟨10.15252/embr.202357424⟩.
-
2022IFN-I inducible miR-3614-5p targets ADAR1 isoforms and fine tunes innate immune activation., Front Immunol 2022 ; 13(): 939907.
-
2021Herpes simplex encephalitis in a patient with a distinctive form of inherited IFNAR1 deficiency., J Clin Invest 2021 Jan; 131(1): .
-
2021Altered Immune Phenotypes and HLA-DQB1 Gene Variation in Multiple Sclerosis Patients Failing Interferon β Treatment., Front Immunol 2021 ; 12(): 628375.
-
2020An Old Cytokine Against a New Virus?, J Interferon Cytokine Res 2020 08; 40(8): 425-428.
-
2020COPZ1 depletion in thyroid tumor cells triggers type I IFN response and immunogenic cell death., Cancer Lett 2020 04; 476(): 106-119.
-
2020Human Ubiquitin-Specific Peptidase 18 Is Regulated by microRNAs via the 3’Untranslated Region, A Sequence Duplicated in Long Intergenic Non-coding RNA Genes Residing in chr22q11.21., Front Genet 2020 ; 11(): 627007.
-
2020Two common disease-associated TYK2 variants impact exon splicing and TYK2 dosage., PLoS One 2020 ; 15(1): e0225289.
-
2019USP18 and ISG15 coordinately impact on SKP2 and cell cycle progression, Sci Rep 2019 Mar;9(1):4066.
-
2018Tuberculosis and impaired IL-23-dependent IFN-γ immunity in humans homozygous for a common missense variant, Sci Immunol 2018 Dec;3(30).
-
+Voir la liste complète de publications